Spectrum Pharmaceuticals Inc narrowed III. Quarter net loss per share of $-0.12 compare to net loss per share of $-0.21 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.17 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.12
$
0 Mill
$+0.09
Unch.
Spectrum Pharmaceuticals Inc 's Revenue
fell by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Spectrum Pharmaceuticals Inc is Expected to report next financial results on March 16, 2023.
Spectrum Pharmaceuticals Inc 's
in III. Quarter recorded net loss of $-21.925 million, an improvement compare to net loss of $-33.084 million in III. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-29.048 million realized in previous quarter.
